US EditionDrugmaker Sinergium to share bird flu vaccine data globally, says WHO
- The World Health Organization announced a project to develop bird flu vaccines in poorer countries using messenger RNA technology on July 29.
- Sinergium plans to establish proof-of-concept for its candidate vaccines, sharing resources with manufacturers in poorer countries.
- The WHO maintains that while the risk to the public from avian influenza is low, it could lead to a future pandemic due to its animal circulation.
20 Articles
20 Articles
La Organización Mundial de la Salud (OMS) anunció este lunes una iniciativa para desarrollar vacunas contra la gripe aviar en los países más pobres o en vías de desarrollo con la tecnología del ARN mensajero, un proyecto liderado por una farmacéutica argentina. La empresa biofarmacéutica Sinergium Biotech, en Argentina, encabeza el proyecto y comenzó a desarrollar vacunas candidatas contra el virus de la gripe aviar H5N1, indicó la OMS en un com…
Drugmaker Sinergium to share bird flu vaccine data globally, says WHO
Bird flu vaccine developer Sinergium Biotech will share its data with manufacturers in low and middle-income countries to help to accelerate a fair rollout if a pandemic occurs, the World Health Organization said on Monday.
WHO spearheads new initiative for mRNA bird flu vaccine advancement
The World Health Organization announced Monday a new project to accelerate the development in poorer countries of vaccines for human bird flu infections using cutting-edge messenger RNA technology. The WHO said Argentinian manufacturer Sinergium Biotech would lead the effort and had already begun developing candidate H5N1 vaccines. The bird flu H5N1 first emerged in 1996, but since 2020 an exponential growth in outbreaks in birds has occurred in…
The United Nations Agency for Agriculture (FAO) deemed last week that the evolution of avian influenza in the Asia-Pacific region was becoming “alarming” The WHO announced on Monday a
Drugmaker Sinergium to share bird flu vaccine data globally, says WHO
GENEVA, Switzerland – Bird flu vaccine developer Sinergium Biotech will share its data with manufacturers in low and middle-income countries to help to accelerate a fair rollout if a pandemic occurs, the World Health Organization said on Monday, July 29. The Argentine private sector biopharmaceutical company is at an early stage of developing mRNA vaccines against the H5N1 virus and has pledged to share its findings with a network of partner man…
Coverage Details
Bias Distribution
- 67% of the sources are Center
To view factuality data please Upgrade to Premium
